The closing price of Petmed Express, Inc. (NASDAQ: PETS) was $4.11 for the day, down -1.20% from the previous closing price of $4.16. On the day, 534361 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
Our analysis of PETS’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.63 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 4.99. For the most recent quarter (mrq), Quick Ratio is recorded 1.64 and its Current Ratio is at 2.10. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Lake Street on May 25, 2023, initiated with a Buy rating and assigned the stock a target price of $20.
On January 20, 2022, Sidoti Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $32.
On November 18, 2021, Morgan Stanley started tracking the stock assigning a Underweight rating and target price of $25.Morgan Stanley initiated its Underweight rating on November 18, 2021, with a $25 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 09 ’23 when FULGONI GIAN bought 41,000 shares for $7.34 per share. The transaction valued at 301,124 led to the insider holds 109,510 shares of the business.
Hulett Mathew N bought 13,850 shares of PETS for $100,551 on Nov 03 ’23. The CEO & President now owns 613,850 shares after completing the transaction at $7.26 per share. On Nov 03 ’23, another insider, Chambers Christine, who serves as the CFO of the company, bought 6,888 shares for $7.26 each. As a result, the insider paid 50,007 and bolstered with 19,888 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.32 while its Price-to-Book (P/B) ratio in mrq is 0.76.
Stock Price History:
Over the past 52 weeks, PETS has reached a high of $16.18, while it has fallen to a 52-week low of $4.09.
Shares Statistics:
A total of 21.08M shares are outstanding, with a floating share count of 20.15M. Insiders hold about 4.73% of the company’s shares, while institutions hold 72.93% stake in the company.
Earnings Estimates
The firm’s stock currently is rated by U.S. Global Jets ETF analysts. The consensus estimate for the next quarter is $2.08, with high estimates of $1.40 and low estimates of $4.11.
Analysts are recommending an EPS of between $Consumer Cyclical and $Healthcare for the fiscal current year, implying an average EPS of $Technology.
